Learn / DMRA
NASDAQ: DMRA
Damora Therapeutics (DMRA) stock, explained like you're 5
Damora Therapeutics trades on the Nasdaq under the ticker DMRA. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.3 billion dollars.
- Ticker
- DMRA
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.3 billion dollars
Is Damora Therapeutics a small, medium or large cap company?
No. Damora Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Damora Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves DMRA stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- (DMRA) Volatility Zones as Tactical Triggers (Stock Traders Daily)
- Damora Therapeutics (DMRA) Stock Looks Above Fair Value On Book Value (Yahoo Finance)
- $DMRA stock is down 10% today. Here's what we see in our data. (Quiver Quantitative)
- symbol__ Stock Quote Price and Forecast (CNN)
- Using personal funds, CEO Jennifer Jarrett buys Damora Therapeutics (DMRA) shares at $20.23 each. (Stock Titan)
Follow DMRA in your daily brief
Each trading day at 5 PM ET we post what happened to Damora Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow DMRA
Questions about Damora Therapeutics stock
What does Damora Therapeutics do?
Damora Therapeutics trades on the Nasdaq under the ticker DMRA. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.3 billion dollars.
What is the ticker symbol for Damora Therapeutics?
Damora Therapeutics trades under the ticker DMRA on the Nasdaq.
What is Damora Therapeutics's market cap?
Damora Therapeutics is a small cap stock with a market cap of about 1.3 billion dollars.
How does Damora Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves DMRA stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow DMRA stock every day?
Add DMRA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.